Wiggin and Dana Lawyers Recognized by LMG Life Sciences

By: Wiggin & Dana | 8 Shares 100 Reads

July 13, 2012 // Franchising.com // Stamford – Wiggin and Dana is pleased to announce Biotechnology and Life Sciences Partners Jim Farrington and Patti Melick have been selected as Life Science Stars in the inaugural edition of LMG Life Sciences. Both partners were recognized in the directory's finance and transactional section, which includes Mergers and Acquisitions and Licensing and Collaboration. Wiggin and Dana was also recognized among a select group of eleven law firms in the area of Licensing and Collaboration.

For three decades the attorneys in the Wiggin and Dana Biotechnology and Life Sciences Practice Group have served as counsel to large multinational pharmaceutical companies, world-class universities and dynamic, emerging biotechnology companies from across the United States and around the world, including Canada, Denmark, Israel, Norway, Sweden, Switzerland and other European countries. The Practice Group regularly assists clients in a variety of vital matters, including mergers and acquisitions, collaborative research, development and licensing arrangements, intellectual property, and corporate financing.

LMG Life Sciences 2012 takes a multi-disciplinary approach to the legal industry servicing companies in the biotech, agritech, pharmaceutical and medical device industries. Research for the publication was based on reviewing nearly 1,000 interviews and surveys completed by 600 attorneys in the United States and from public information and client feedback. One interviewed client noted, "They are quite pragmatic and are very knowledgeable. They understand my company and the industry very well."

For more information about the standards for inclusion in LMG Life Sciences 2012, please go to: http://www.managingip.com/IssueArticle/3047223/Supplements/Methodology.html?supplementListId=85815

###